HONG KONG--(BUSINESS WIRE)--July 13, 2006--American Oriental Bioengineering, Inc. (AMEX: AOB - News): American Oriental Bioengineering, Inc. (AMEX: AOB - News), a leading manufacturer and distributor of pharmaceutical and nutraceutical products in China, provides update on the acquisition of Guangxi Lingfeng Pharmaceutical Company Limited (GLP). GLP is a manufacturer of plant-based pharmaceutical products in China, specializing in pediatrics, gynecopathy and medicines for the treatment of digestive and respiratory system illnesses.
